ブラジルのワクチンなし感染者の重症化率は4%だがSinovac接種者では0%だ、と

SInovacワクチンはWHOが接種を推奨する基準を僅かに上回る有効率だが既に19国が輸入済み　https://t.co/bjcWJTlIYM　トルコの治験では有効率83.5%だが南米で流通する変異株には効きにくい模様。しかし重要なのは重症化を防ぐ効果。ブラジルのワクチンなし感染者の重症化率は4%だがSinovac接種者では0% pic.twitter.com/fPxIFHqlB6

— Spica (@Kelangdbn) April 17, 2021

Economistが読めないのでGlobal timesでみると

Sinovac vaccine effective against virus variants in Brazil; efficacy rises if injection interval is more than 21 days
By
Hu YuweiPublished: Apr 12, 2021 10:43 PM Updated: Apr 13, 2021 0

The primary efficacy against symptomatic COVID-19 is 50.7 percent. The vaccine is 83.7 percent effective in preventing cases requiring assistance, rising from 78 percent in data released in January. It is 100 percent effective against moderate and severe cases in the randomized, double-blind, placebo-controlled phase III clinical trial involving 12,396 participants, the statistics revealed. 

すごいね。

重症化しなければいいんだよね。